Amazon.com Analyst Ratings
Alphabet Analyst Ratings
Major bank rating | Needham: Raises Apple's target price to $260 and suggests it should follow Amazon's lead in establishing an advertising business.
Barclays Adjusts Price Target on Eli Lilly to $1,025 From $913
Meta Platforms Analyst Ratings
TD Cowen Maintains Buy on Meta Platforms, Raises Price Target to $600
Needham Adjusts Price Target on Apple to $260 From $220, Maintains Buy Rating
TD Cowen Adjusts Price Target on Meta Platforms to $600 From $530, Keeps Buy Rating
TD Cowen Adjusts Price Target on Amazon.com to $245 From $225, Keeps Buy Rating
Piper Sandler raised the target price for Apple to $225.
B of A Securities Maintains Buy on Apple, Maintains $230 Price Target
Microsoft Analyst Ratings
Argus Research Maintains Buy on Microsoft, Raises Price Target to $526
Roth MKM Maintains Buy on Amazon.com, Maintains $210 Price Target
Jefferies Financial upgraded Amazon's target price to $235 and rated it as a "buy".
US stock anomaly | Semiconductor sector rises, KeyBanc raises target price for multiple chip stocks.
KeyBanc Raises Price Target on NVIDIA to $180 From $130, Maintains Overweight Rating
Piper Sandler raised its target price for Apple, but warned that the bullish news has already been reflected in the stock price.
UBS Group raised Nvidia's target price to $150.
Bank rating | Goldman Sachs: Eli Lilly's acquisition of Morphic has strategic significance with a target price of $793.